Response to anti-HCV therapy in HIV-HCV-coinfected patients: Does the lipid profile really have an effect?

Antiviral Therapy

Volumn 15, Issue 5, 2010, Pages 797-800

  Petit, Jean Michel ^a,b   Carrat, Fabrice ^c   Duong, Michel ^a   Halfon, Philippe ^d   Duvillard, Laurence ^b   Bani Sadr, Firouzé ^e   Chavanet, Pascal ^a   Cacoub, Patrice ^f   Piroth, Lionel ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b Institut Médical de Génétique et d Immunologie   (France)

^c INSERM   (France)

^d Hospital Ambroise Pare   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f Sorbonne Université   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PEGINTERFERON ALPHA2B; PROTEINASE INHIBITOR; RIBAVIRIN; TRIACYLGLYCEROL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RANK SUM TEST; STATISTICAL SIGNIFICANCE; STEATOSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON ALFA-2B; LIPIDS; POLYETHYLENE GLYCOLS; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 77957328850     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1582     Document Type: Article

References (14)

1. Favre D, Muellhaupt B. Potential cellular receptors involved in hepatitis C virus entry into cells. Lipids Health Dis 2005; 4:9. (Pubitemid 41006635)
2. Agnello V, Abel G, Elfahal M, Knight G, Zhang Q. Hepatitis C virus and other flaviviridae viruses enter cells via low-density lipoprotein receptor. Proc Natl Acad Sci U S A 1999; 96:12766-12771. (Pubitemid 29513577)
3. Molina S, Castet V, Fournier-Wirth C, et al. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 2007; 46:411-419.
4. Gopal K, Johnson T, Gopal S, et al. Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment. Hepatology 2006; 44:335-340.
5. Backus LI, Boothroyd DB, Phillips BR, Mole LA. Predictors of response of US veterans to treatment for the hepatitis C virus. Hepatology 2007; 46:37-47. (Pubitemid 47171919)
6. del Valle J, Mira J, de los Santos I, et al. Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients. AIDS 2008; 22:923-930. (Pubitemid 351652242)
7. Merchante N, de los Santos-Gil I, Merino D, et al. Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients. J Hepatol 2009; 50:684-692.
8. Carrat F, Bani-Sadr F, Pol S, et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004; 292:2839-2848.
9. Bedossa P, Moucari R, Chelbi E, et al. Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study. Hepatology 2007; 46:380-387.
10. Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001; 34:428-434. (Pubitemid 32240823)
11. Petit JM, Benichou M, Duvillard L, et al. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Am J Gastroenterol 2003; 98:1150-1154. (Pubitemid 36733780)
12. Perlemuter G, Sabile A, Letteron P, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002; 16:185-194. (Pubitemid 34113012)
13. Petit JM, Duong M, Duvillard L, et al. LDL-receptors expression in HIV-infected patients: relations to antiretroviral therapy, hormonal status, and presence of lipodystrophy. Eur J Clin Invest 2002; 32:354-359. (Pubitemid 36228396)
14. Vallet-Pichard A, Pol S. Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection. J Hepatol 2006; 44 Suppl 1:S28-S34. (Pubitemid 43053870)